1. Home
  2. TRST vs CERT Comparison

TRST vs CERT Comparison

Compare TRST & CERT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo TrustCo Bank Corp NY

TRST

TrustCo Bank Corp NY

HOLD

Current Price

$50.48

Market Cap

858.9M

Sector

Finance

ML Signal

HOLD

CERT

Certara Inc.

HOLD

Current Price

$5.24

Market Cap

860.9M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
TRST
CERT
Founded
1902
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Retail: Computer Software & Peripheral Equipment
Sector
Finance
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
858.9M
860.9M
IPO Year
1994
2020

Fundamental Metrics

Financial Performance
Metric
TRST
CERT
Price
$50.48
$5.24
Analyst Decision
Buy
Analyst Count
0
10
Target Price
N/A
$11.67
AVG Volume (30 Days)
67.4K
3.2M
Earning Date
04-21-2026
05-11-2026
Dividend Yield
3.25%
N/A
EPS Growth
26.46
87.50
EPS
0.91
N/A
Revenue
N/A
$418,838,000.00
Revenue This Year
N/A
$4.18
Revenue Next Year
N/A
$5.39
P/E Ratio
$55.44
N/A
Revenue Growth
N/A
8.75
52 Week Low
$30.17
$4.45
52 Week High
$50.52
$13.88

Technical Indicators

Market Signals
Indicator
TRST
CERT
Relative Strength Index (RSI) 67.76 44.91
Support Level $41.96 $5.19
Resistance Level N/A $6.47
Average True Range (ATR) 0.89 0.35
MACD 0.11 -0.03
Stochastic Oscillator 82.95 39.65

Price Performance

Historical Comparison
TRST
CERT

About TRST TrustCo Bank Corp NY

Trustco Bank Corp N Y is a savings and loan holding company. The core part of a business consists of accepting deposits and making loans and investments. It offers a range of both personal and business banking services. The company's product includes savings accounts; retirement accounts; money market account; mortgages; building loans; auto loans and others. The company derives revenue from the business of Banking. TrustCo lends in the geographic territory of its branch locations in New York, Florida, Massachusetts, New Jersey, and Vermont.

About CERT Certara Inc.

Certara Inc accelerates medicines to patients using biosimulation software and technology to transform traditional drug discovery and development. It provides modeling and simulation, regulatory science, and assessment software and services to help clients reduce clinical trials, accelerate regulatory approval, and increase patient access to medicines. The company has its business presence in the Americas, which is also its key revenue-generating market, EMEA, and the Asia Pacific region.

Share on Social Networks: